fbpx Back to Top

Pulmonary Hypertension

Get Help with Your Treatment

Apply Online or call 1-866-316-7263

 

Program Status

Currently Closed – We are no longer accepting or processing applications for new or renewal patients.

 

The PAN Foundation’s Pulmonary Hypertension fund is currently closed. As of December 9, 2019, The Assistance Fund is accepting applications.

 

For current information, log in to FundFinder.

 

Assistance Amount

$5,300 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for pulmonary hypertension.
  2. The patient must have Medicare health insurance that covers his or her qualifying medication or product. 
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Adalat Cc (nifedipine)
  • Adcirca (tadalafil)
  • Adempas (riociguat)
  • Afeditab Cr (nifedipine)
  • Aldactone (spironolactone)
  • Alyq (tadalafil)
  • Ambrisentan (ambrisentan)
  • Amlodipine Besylate (amlodipine besylate)
  • Bosentan (bosentan)
  • Bumetanide (bumetanide)
  • Cardizem (diltiazem hcl)
  • Cardizem Cd (diltiazem hcl)
  • Carospir (spironolactone)
  • Cartia Xt (diltiazem hcl)
  • Coumadin (warfarin sodium)
  • Demadex (torsemide)
  • Diltiazem 12hr Er (diltiazem hcl)
  • Diltiazem 24hr Er (diltiazem hcl)
  • Diltiazem 24hr Er (cd) (diltiazem hcl)
  • Diltiazem 24hr Er (la) (diltiazem hcl)
  • Diltiazem 24hr Er (xr) (diltiazem hcl)
  • Dilt-Xr (diltiazem hcl)
  • Eplerenone (eplerenone)
  • Epoprostenol Sodium (epoprostenol sodium (glycine))
  • Flolan (epoprostenol sodium (glycine))
  • Furosemide (furosemide)
  • Furosemide-0.9% Nacl (furosemide in 0.9 % sodium chloride)
  • Inspra (eplerenone)
  • Jantoven (warfarin sodium)
  • Lasix (furosemide)
  • Letairis (ambrisentan)
  • Matzim La (diltiazem hcl)
  • Metolazone (metolazone)
  • Nifedipine Er (nifedipine)
  • Norvasc (amlodipine besylate)
  • Opsumit (macitentan)
  • Orenitram Er (treprostinil diolamine)
  • Procardia Xl (nifedipine)
  • Remodulin (treprostinil sodium)
  • Revatio (sildenafil citrate)
  • Sildenafil (sildenafil citrate)
  • Spironolactone (spironolactone)
  • Tadalafil (tadalafil)
  • Taztia Xt (diltiazem hcl)
  • Tiazac (diltiazem hcl)
  • Torsemide (torsemide)
  • Tracleer (bosentan)
  • Treprostinil (treprostinil sodium)
  • Tyvaso (treprostinil)
  • Tyvaso Institutional Start Kit (treprostinil/nebulizer and accessories)
  • Tyvaso Refill Kit (treprostinil/nebulizer accessories)
  • Tyvaso Starter Kit (treprostinil/nebulizer and accessories)
  • Uptravi (selexipag)
  • Veletri (epoprostenol sodium (arginine))
  • Ventavis (iloprost tromethamine)
  • Warfarin Sodium (warfarin sodium)

Diagnosis Codes:

ICD-10: I27.0, I27.20, I27.21, I27.22, I27.23, I27.24, I27.29, I27.81, I27.83, I27.89, I27.9

 

About the Disease:

Pulmonary hypertension (PH) is a type of high blood pressure that affects arteries in the lungs and heart. PH is a rare disease that affects the circulatory system.

 

Source: National Institutes of Health